Results 211 to 220 of about 42,642 (342)

Myosteatosis as a New Risk Factor of Surgical Complications in Kidney Transplant Recipients: A Retrospective Study

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Background Computed tomography (CT) scan–defined myosteatosis is a common feature in ESKD patients receiving kidney transplantation (KT) and is associated with mortality after KT. We aimed to explore the impact of myosteatosis and other CT scan based morphometric data on the occurrence of early surgical complications after KT.
Antoine Morel, Yaniss Ouamri, Lauriane Ségaux, Louai Zaidan, Michael Moryoussef, Sébastien Mulé, Cécile Maud Champy, Edouard Reizine, Alexandre Ingels, Alain Luciani, Philippe Grimbert, Florence Canouï‐Poitrine, Marie Matignon, Frédéric Pigneur, Thomas Stehlé   +14 more
wiley   +1 more source

Bidirectional Interaction Between Chronic Kidney Disease and <i>Porphyromonas gingivalis</i> Infection Drives Inflammation and Immune Dysfunction. [PDF]

J Immunol Res
Adamowicz K, Lima Ribeiro AS, Golda A, Wadowska M, Potempa J, Schmaderer C, Anders HJ, Koziel J, Lech M.   +8 more
europepmc   +1 more source

Clinical and experimental studies on guanidino compounds in uremia

, 1975
Michiko Matsumoto
openalex   +2 more sources

Impaired atrial natriuretic factor systemic clearance contributes to its higher levels in uremia. [PDF]

, 1992
Ramón Paniagua, Martha Franco, Ernesto Hernández Rodríguez, Gabriela Sánchez, Gunther Hernández Morales, Jaime Herrera-Acosta   +5 more
openalex   +1 more source

Risks of All‐Cause Mortality in Adults With Chronic Kidney Disease With Sarcopenia or Obesity: A Population‐Based Study

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Background The relationship between obesity, sarcopenic obesity and all‐cause mortality in chronic kidney disease (CKD) patients remains controversial. This study aims to investigate the role of low muscle mass and fat mass in the risk of all‐cause mortality in CKD patients in the United States.
Jin'e Li, Hua Tu, Yuying Zhang, Shiqi Yang, Peng Yu, Jianping Liu   +5 more
wiley   +1 more source

Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation. [PDF]

World J Nephrol
Chafekar D.
europepmc   +1 more source

Sexual Dysfunction in Uremia [PDF]

, 1999
Biff F. Palmer
openalex   +1 more source

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Background Sarcopenia is defined as the loss of muscle mass, strength, and/or performance. It is strongly associated with all‐cause mortality. Fibroblast growth factor 23 (FGF23) is markedly elevated in patients with chronic kidney disease, especially those receiving maintenance dialysis.
Limy Wong, Rachel Kenny, Jenny Y. Y. Ooi, Yung Shing Tsang, Emily Schembri, Lawrence P. McMahon   +5 more
wiley   +1 more source

An Unusual Cause of Chest Pain in a Pediatric Patient on Hemodialysis. [PDF]

Kidney360
Glenn Lecea E, Favel K.
europepmc   +1 more source

Acute uremia suppresses leucine-induced signal transduction in skeletal muscle.

Kidney International, 2014
Kevin L McIntire, Yu Chen, S. Sood, R. Rabkin   +3 more
semanticscholar   +1 more source